The first Lipitor lawsuit scheduled for trial in the South Carolina multidistrict litigation has been pushed back from November 4 to January 13 of next year. U.S. District Judge Richard Gergel, who is presiding over the federal Lipitor litigation, cited the Court’s heavy criminal caseload, which legally takes precedence on the Court’s civil docket.
Over 2,500 Lipitor diabetes lawsuits are currently pending in the U.S. District Court for the District ...
continue reading...The Institute of Safe Medication Practices (ISMP) has released the 2015 Annual QuarterWatch drug safety report, providing an overview of domestic drug-related adverse events as submitted to the U.S. Food and Drug Administration (FDA) in 2014. In it, the ISMP considered the high number of Lipitor diabetes lawsuits that have accumulated and what they may indicate about the safety of statins like Lipitor.
Lipitor ...
continue reading...As Lipitor lawsuits continue to mount, it can be hard to keep track of the number of plaintiffs involved in the Lipitor multidistrict litigation. One year ago, Lipitor lawsuits were estimated to number just under 1,000. But many Lipitor lawsuits include more than one plaintiff. As one lawyer set to representing Lipitor plaintiffs in the South Carolina multidistrict litigation was reported to have said in a Reuters article, the ...
What began as 56 federal actions against the maker of the world’s best selling drug has grown into a thousand-member multidistrict litigation. And with the first trial just months away, Lipitor lawsuits continue to pile up. So just what did Pfizer do to draw the legal fire of thousands of former Lipitor users? Several allegations have been leveled at the New York–based pharmaceutical giant, ranging from overly aggressive ...
At least a thousand Lipitor lawsuits have already been filed as part of a South Carolina multidistrict litigation. Plaintiffs in Lipitor lawsuits claim pharmaceutical giant Pfizer marketed its cholesterol drug without regard for the safety of patients, concealing information about the link between Lipitor and diabetes. As Lipitor lawsuits continue to pour in, many are wondering just how large the litigation will grow. The lead lawyer ...
Pfizer recently tried to have 94 Lipitor lawsuits dismissed in the South Carolina Lipitor multidistrict litigation. While 44 of these were successfully removed from litigation, the district court denied Pfizer’s attempt to dismiss 50 more on the grounds of unfulfilled discovery obligations.
The Lipitor lawsuits in question are part of MDLÂ 2502, which includes more than 2,000 Lipitor lawsuits. The multidistrict litigation was centralized in the U.S. District Court for ...
continue reading...
